首页 > 最新文献

Circulation: Cardiovascular Quality and Outcomes最新文献

英文 中文
ORBITA Trials Are Not Justification to Promote a PCI-First Strategy in Nonacute Myocardial Ischemic Syndromes. ORBITA 试验并不能证明在非急性心肌缺血综合征中推广 PCI 优先策略是正确的。
Pub Date : 2024-09-17 DOI: 10.1161/circoutcomes.124.011268
William E Boden,Raffaele De Caterina
{"title":"ORBITA Trials Are Not Justification to Promote a PCI-First Strategy in Nonacute Myocardial Ischemic Syndromes.","authors":"William E Boden,Raffaele De Caterina","doi":"10.1161/circoutcomes.124.011268","DOIUrl":"https://doi.org/10.1161/circoutcomes.124.011268","url":null,"abstract":"","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"65 1","pages":"e011268"},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Future of Patient-Reported Outcomes: Bringing Patients' Voices Into Health Care. 患者报告结果的未来:将患者的声音带入医疗保健。
Pub Date : 2024-09-17 DOI: 10.1161/circoutcomes.124.010008
John A Spertus,Alexander T Singh,Suzanne V Arnold
{"title":"Future of Patient-Reported Outcomes: Bringing Patients' Voices Into Health Care.","authors":"John A Spertus,Alexander T Singh,Suzanne V Arnold","doi":"10.1161/circoutcomes.124.010008","DOIUrl":"https://doi.org/10.1161/circoutcomes.124.010008","url":null,"abstract":"","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"7 1","pages":"e010008"},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Current Clinical Guidelines Set Percutaneous Coronary Intervention Up to Fail? Insights From the ORBITA-2 Trial. 现行临床指南是否使经皮冠状动脉介入治疗失败?ORBITA-2 试验的启示。
Pub Date : 2024-09-17 DOI: 10.1161/circoutcomes.124.011201
Christopher A Rajkumar,Rasha K Al-Lamee
{"title":"Do Current Clinical Guidelines Set Percutaneous Coronary Intervention Up to Fail? Insights From the ORBITA-2 Trial.","authors":"Christopher A Rajkumar,Rasha K Al-Lamee","doi":"10.1161/circoutcomes.124.011201","DOIUrl":"https://doi.org/10.1161/circoutcomes.124.011201","url":null,"abstract":"","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"15 1","pages":"e011201"},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arguing Angina: ORBITA's Challenge to Conventional Wisdom on PCI. 争论心绞痛:ORBITA 对 PCI 传统智慧的挑战。
Pub Date : 2024-09-17 DOI: 10.1161/circoutcomes.124.011547
Brahmajee K Nallamothu
{"title":"Arguing Angina: ORBITA's Challenge to Conventional Wisdom on PCI.","authors":"Brahmajee K Nallamothu","doi":"10.1161/circoutcomes.124.011547","DOIUrl":"https://doi.org/10.1161/circoutcomes.124.011547","url":null,"abstract":"","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"1 1","pages":"e011547"},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unequal Management and Outcomes Among Asian American Patients With Coronary Heart Disease. 美国亚裔冠心病患者的不平等管理和治疗效果。
Pub Date : 2024-09-10 DOI: 10.1161/circoutcomes.124.011440
Robert C Kaplan,Kwun Chuen Gary Chan
{"title":"Unequal Management and Outcomes Among Asian American Patients With Coronary Heart Disease.","authors":"Robert C Kaplan,Kwun Chuen Gary Chan","doi":"10.1161/circoutcomes.124.011440","DOIUrl":"https://doi.org/10.1161/circoutcomes.124.011440","url":null,"abstract":"","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"11 1","pages":"e011440"},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142178527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myocardial Infarction Quality of Care and Outcomes in Asian Ethnic Groups in the United States. 美国亚裔群体的心肌梗死护理质量和结果。
Pub Date : 2024-09-10 DOI: 10.1161/circoutcomes.124.011097
Aishwarya Vijay,Xiaoning Huang,Mark D Huffman,Namratha R Kandula,Donald M Lloyd-Jones,Powell O Jose,Eugene Yang,Abhinav Goyal,Sadiya S Khan,Nilay S Shah
BACKGROUNDNational-level differences in myocardial infarction (MI) quality of care among Asian patients in the United States are unclear. We assessed the quality of MI care in the 6 largest US Asian ethnic groups.METHODSPatients aged ≥18 years with ST-segment-elevation MI or non-ST-segment-elevation MI in the Get With The Guidelines-Coronary Artery Disease registry (711 US hospitals, 2015-2021) were assessed. The odds of MI-related quality of care and process outcomes were evaluated in Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese, and other Asian adults compared with non-Hispanic White adults. Sex-stratified logistic regression models were adjusted for age and clinical characteristics.RESULTSThere were 5691 Asian patients (1520 Asian Indian, 422 Chinese, 430 Filipino, 114 Japanese, 283 Korean, 553 Vietnamese, and 2369 other Asian) and 141 271 non-Hispanic White patients, overall 30% female, and mean age of 66.5 years. Relative to non-Hispanic White adults, among patients with ST-segment-elevation MI, door-to-ECG time ≤10 minutes was less likely in Asian Indian (adjusted odds ratio [aOR], 0.64 [95% CI, 0.50-0.82]), Chinese (aOR, 0.65 [95% CI, 0.46-0.93]), and Korean (aOR, 0.57 [95% CI, 0.33-0.97]) men and in other Asian women (aOR, 0.61 [95% CI, 0.41-0.90]). Door-to-balloon time ≤90 minutes was less likely in Asian Indian men (aOR, 0.71 [95% CI, 0.56-0.90]) and Filipina women (aOR, 0.48 [95% CI, 0.24-0.98]). In patients with ST-segment-elevation MI or non-ST-segment-elevation MI, optimal medical therapy for MI was less likely in Korean men (aOR, 0.65 [95% CI, 0.47-0.90]) and more likely in Asian Indian men (aOR, 1.22 [95% CI, 1.06-1.40]) and women (aOR, 1.32 [95% CI, 1.04-1.67]) and Filipina women (aOR, 1.84 [95% CI, 1.27-2.67]).CONCLUSIONSMI quality of care varies among US Asian patients with ST-segment-elevation MI and non-ST-segment-elevation MI. Quality improvement programs must identify and address the factors that result in suboptimal MI quality of care among US Asian patients.
背景美国亚裔患者心肌梗死(MI)治疗质量的国家级差异尚不明确。我们评估了美国 6 大亚裔群体的心肌梗死护理质量。方法评估了《指南》-冠状动脉疾病登记(2015-2021 年,美国 711 家医院)中年龄≥18 岁、ST 段抬高型心肌梗死或非 ST 段抬高型心肌梗死患者。与非西班牙裔白人成人相比,评估了亚裔印度人、中国人、菲律宾人、日本人、韩国人、越南人和其他亚裔成人与心肌梗死相关的护理质量和流程结果的几率。结果共有 5691 名亚裔患者(1520 名亚裔印度人、422 名中国人、430 名菲律宾人、114 名日本人、283 名韩国人、553 名越南人和 2369 名其他亚裔人)和 141271 名非西班牙裔白人患者,其中女性患者占 30%,平均年龄为 66.5 岁。与非西班牙裔白人成人相比,在 ST 段抬高型心肌梗死患者中,印度裔亚裔患者的门到心电图时间≤10 分钟的可能性较小(调整后的几率比 [aOR],0.64[95%CI,0.50-0.82])、中国人(aOR,0.65[95%CI,0.46-0.93])和韩国人(aOR,0.57[95%CI,0.33-0.97])以及其他亚洲女性(aOR,0.61[95%CI,0.41-0.90])。印度裔亚裔男性(aOR,0.71 [95% CI,0.56-0.90])和菲律宾裔女性(aOR,0.48 [95% CI,0.24-0.98])门到气球时间≤90 分钟的可能性较低。在 ST 段抬高型心肌梗死或非 ST 段抬高型心肌梗死患者中,韩国男性(aOR,0.65 [95% CI,0.47-0.90])和印度亚洲男性(aOR,1.22 [95% CI,1.结论 ST 段抬高型心肌梗死和非 ST 段抬高型心肌梗死的美国亚裔患者的护理质量存在差异。质量改进计划必须找出并解决导致美国亚裔患者心肌梗死护理质量不达标的因素。
{"title":"Myocardial Infarction Quality of Care and Outcomes in Asian Ethnic Groups in the United States.","authors":"Aishwarya Vijay,Xiaoning Huang,Mark D Huffman,Namratha R Kandula,Donald M Lloyd-Jones,Powell O Jose,Eugene Yang,Abhinav Goyal,Sadiya S Khan,Nilay S Shah","doi":"10.1161/circoutcomes.124.011097","DOIUrl":"https://doi.org/10.1161/circoutcomes.124.011097","url":null,"abstract":"BACKGROUNDNational-level differences in myocardial infarction (MI) quality of care among Asian patients in the United States are unclear. We assessed the quality of MI care in the 6 largest US Asian ethnic groups.METHODSPatients aged ≥18 years with ST-segment-elevation MI or non-ST-segment-elevation MI in the Get With The Guidelines-Coronary Artery Disease registry (711 US hospitals, 2015-2021) were assessed. The odds of MI-related quality of care and process outcomes were evaluated in Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese, and other Asian adults compared with non-Hispanic White adults. Sex-stratified logistic regression models were adjusted for age and clinical characteristics.RESULTSThere were 5691 Asian patients (1520 Asian Indian, 422 Chinese, 430 Filipino, 114 Japanese, 283 Korean, 553 Vietnamese, and 2369 other Asian) and 141 271 non-Hispanic White patients, overall 30% female, and mean age of 66.5 years. Relative to non-Hispanic White adults, among patients with ST-segment-elevation MI, door-to-ECG time ≤10 minutes was less likely in Asian Indian (adjusted odds ratio [aOR], 0.64 [95% CI, 0.50-0.82]), Chinese (aOR, 0.65 [95% CI, 0.46-0.93]), and Korean (aOR, 0.57 [95% CI, 0.33-0.97]) men and in other Asian women (aOR, 0.61 [95% CI, 0.41-0.90]). Door-to-balloon time ≤90 minutes was less likely in Asian Indian men (aOR, 0.71 [95% CI, 0.56-0.90]) and Filipina women (aOR, 0.48 [95% CI, 0.24-0.98]). In patients with ST-segment-elevation MI or non-ST-segment-elevation MI, optimal medical therapy for MI was less likely in Korean men (aOR, 0.65 [95% CI, 0.47-0.90]) and more likely in Asian Indian men (aOR, 1.22 [95% CI, 1.06-1.40]) and women (aOR, 1.32 [95% CI, 1.04-1.67]) and Filipina women (aOR, 1.84 [95% CI, 1.27-2.67]).CONCLUSIONSMI quality of care varies among US Asian patients with ST-segment-elevation MI and non-ST-segment-elevation MI. Quality improvement programs must identify and address the factors that result in suboptimal MI quality of care among US Asian patients.","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"16 1","pages":"e011097"},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142178528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial 向医疗服务提供者发送高脂血症治疗信息的务实试验(PROMPT-LIPID):随机临床试验
Pub Date : 2024-04-18 DOI: 10.1161/circoutcomes.123.010335
Nimish N. Shah, Lama Ghazi, Yu Yamamoto, Sanchit Kumar, Melissa Martin, Michael Simonov, Ralph J. Riello III, Kamil F. Faridi, Tariq Ahmad, F. Perry Wilson, Nihar R. Desai
BACKGROUND:Lipid-lowering therapy (LLT) is underutilized for very high-risk atherosclerotic cardiovascular disease. PROMPT-LIPID (PRagmatic Trial of Messaging to Providers about Treatment of HyperLIPIDemia) sought to determine whether electronic health record (EHR) alerts improve 90-day LLT intensification in patients with very high-risk atherosclerotic cardiovascular disease.METHODS:PROMPT-LIPID was a pragmatic trial in which cardiovascular and internal medicine clinicians within Yale New Haven Health (New Haven, CT) were cluster-randomized to receive an EHR alert with individualized LLT recommendations or no alert for outpatients with very high-risk atherosclerotic cardiovascular disease and LDL-C (low-density lipoprotein cholesterol), ≥70 mg/dL. The primary outcome was 90-day LLT intensification (change to high-intensity statin and addition of ezetimibe or PCSK9i [proprotein subtilisin/kexin type 9 inhibitors]). Secondary outcomes included LDL-C level, proportion of patients with LDL-C of <70 or < 55 mg/dL, rate of major adverse cardiovascular events, ED visit incidence, and 6-month mortality. Results were analyzed using logistic and linear regression clustered at the provider level.RESULTS:The no-alert group included 47 clinicians and 1370 patients (median age, 71 years; 50.1% female, median LDL-C, 93 mg/dL); the alert group included 49 clinicians and 1130 patients (median age, 72 years; 47% female, median LDL-C 91, mg/dL). The primary outcome was observed in 14.1% of patients in the alert group as compared with 10.4% in the no-alert group. There were no differences in any secondary outcomes at 6 months. Among 542 patients whose clinicians (n=46) did not dismiss the EHR alert recommendations, LLT intensification was significantly greater (21.2% versus 10.4%, odds ratio, 2.33 [95% CI, 1.48–3.66]).CONCLUSIONS:With a real-time, targeted, individualized EHR alert as compared with usual care, the proportion of patients with atherosclerotic cardiovascular disease with LLT intensification was numerically higher but not statistically significant. Among clinicians who did not dismiss the alert, there was a > 2-fold increase in LLT intensification. EHR alerts, coupled with strategies to reduce clinician dismissal, may help address persistent gaps in LDL-C management.REGISTRATION:URL: https://www.clinicaltrials.gov; Unique identifier: NCT04394715, https://www.clinicaltrials.gov/ct2/show/study/NCT04394715
背景:对于极高危的动脉粥样硬化性心血管疾病,降脂疗法(LLT)的使用率很低。PROMPT-LIPID(向医疗服务提供者发送有关高脂血症治疗信息的实用试验)旨在确定电子健康记录(EHR)警报是否能改善极高危动脉粥样硬化性心血管疾病患者的 90 天 LLT 强化治疗。方法:PROMPT-LIPID 是一项实用性试验,耶鲁大学纽黑文健康中心(康涅狄格州纽黑文)的心血管和内科临床医生被分组随机分配到接受带有个性化 LLT 建议的电子病历提示或不接受提示的高危动脉粥样硬化性心血管疾病门诊患者中,LDL-C(低密度脂蛋白胆固醇)≥70 mg/dL。主要结果是90天的LLT强化(改用高强度他汀类药物,并添加依折麦布或PCSK9i[蛋白枯草酶/kexin 9型抑制剂])。次要结果包括 LDL-C 水平、LDL-C 为 70 或 55 mg/dL 的患者比例、主要不良心血管事件发生率、急诊室就诊率和 6 个月死亡率。结果:无预警组包括 47 名临床医生和 1370 名患者(中位年龄 71 岁;50.1% 为女性;中位 LDL-C 93 mg/dL);预警组包括 49 名临床医生和 1130 名患者(中位年龄 72 岁;47% 为女性;中位 LDL-C 91 mg/dL)。预警组中有 14.1% 的患者观察到了主要结果,而无预警组中只有 10.4% 的患者观察到了主要结果。6 个月后的任何次要结果均无差异。结论:与常规护理相比,通过实时、有针对性、个性化的电子病历提醒,动脉粥样硬化性心血管疾病患者接受 LLT 加强治疗的比例在数量上有所增加,但无统计学意义。而在未解除警报的临床医生中,LLT强化治疗的比例增加了2倍。电子病历警报加上减少临床医生忽视的策略,可能有助于解决低密度脂蛋白胆固醇管理中持续存在的差距。注册:URL:https://www.clinicaltrials.gov;唯一标识符:NCT04394715, https://www.clinicaltrials.gov/ct2/show/study/NCT04394715
{"title":"Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial","authors":"Nimish N. Shah, Lama Ghazi, Yu Yamamoto, Sanchit Kumar, Melissa Martin, Michael Simonov, Ralph J. Riello III, Kamil F. Faridi, Tariq Ahmad, F. Perry Wilson, Nihar R. Desai","doi":"10.1161/circoutcomes.123.010335","DOIUrl":"https://doi.org/10.1161/circoutcomes.123.010335","url":null,"abstract":"BACKGROUND:Lipid-lowering therapy (LLT) is underutilized for very high-risk atherosclerotic cardiovascular disease. PROMPT-LIPID (PRagmatic Trial of Messaging to Providers about Treatment of HyperLIPIDemia) sought to determine whether electronic health record (EHR) alerts improve 90-day LLT intensification in patients with very high-risk atherosclerotic cardiovascular disease.METHODS:PROMPT-LIPID was a pragmatic trial in which cardiovascular and internal medicine clinicians within Yale New Haven Health (New Haven, CT) were cluster-randomized to receive an EHR alert with individualized LLT recommendations or no alert for outpatients with very high-risk atherosclerotic cardiovascular disease and LDL-C (low-density lipoprotein cholesterol), ≥70 mg/dL. The primary outcome was 90-day LLT intensification (change to high-intensity statin and addition of ezetimibe or PCSK9i [proprotein subtilisin/kexin type 9 inhibitors]). Secondary outcomes included LDL-C level, proportion of patients with LDL-C of &lt;70 or &lt; 55 mg/dL, rate of major adverse cardiovascular events, ED visit incidence, and 6-month mortality. Results were analyzed using logistic and linear regression clustered at the provider level.RESULTS:The no-alert group included 47 clinicians and 1370 patients (median age, 71 years; 50.1% female, median LDL-C, 93 mg/dL); the alert group included 49 clinicians and 1130 patients (median age, 72 years; 47% female, median LDL-C 91, mg/dL). The primary outcome was observed in 14.1% of patients in the alert group as compared with 10.4% in the no-alert group. There were no differences in any secondary outcomes at 6 months. Among 542 patients whose clinicians (n=46) did not dismiss the EHR alert recommendations, LLT intensification was significantly greater (21.2% versus 10.4%, odds ratio, 2.33 [95% CI, 1.48–3.66]).CONCLUSIONS:With a real-time, targeted, individualized EHR alert as compared with usual care, the proportion of patients with atherosclerotic cardiovascular disease with LLT intensification was numerically higher but not statistically significant. Among clinicians who did not dismiss the alert, there was a &gt; 2-fold increase in LLT intensification. EHR alerts, coupled with strategies to reduce clinician dismissal, may help address persistent gaps in LDL-C management.REGISTRATION:URL: https://www.clinicaltrials.gov; Unique identifier: NCT04394715, https://www.clinicaltrials.gov/ct2/show/study/NCT04394715","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140617694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Policy Strategies to Advance Cardiovascular Health in the United States—Building on a Century of Progress 促进美国心血管健康的政策战略--以一个世纪的进步为基础
Pub Date : 2024-04-16 DOI: 10.1161/circoutcomes.123.010149
Rishi K. Wadhera, Karen E. Joynt Maddox

The US health care system has undergone remarkable transformation over the past century. Policy proposals to create a national health insurance system date back decades and have faced multiple political headwinds but focused on similar and consistent themes: achieving universal health care coverage, containing high and rising health care costs, and increasing competition among private plans.


When President Obama came to office in 2008, his administration faced compounding health system challenges. Nearly 45 million Americans lacked health insurance coverage. Concerns that private plans were overtly prioritizing profits rather than patients had intensified. National health care costs had risen to 17% of the gross domestic product. At the same time, health outcomes in the United States were worse than comparable countries. In 2010, President Obama signed the Affordable Care Act (ACA) into law, which had 3 areas of focus: expanding coverage through public and private payers, reforming health insurance markets to be more patient-friendly, and improving quality of care and reducing spending through value-based payment programs.


The ACA addressed high noninsurance rates in the United States with an individual mandate, which required most people to obtain health insurance, and by creating government-run public marketplaces (exchanges) where individuals could obtain insurance plans, often subsidized for lower income buyers. At the same time, the ACA also expanded Medicaid coverage to all adults with incomes up to 138% of the federal poverty level. Though this was intended to be a national expansion, a later Supreme Court challenge established it as optional; consequently, 25 states (including DC) expanded Medicaid in 2014, and an additional 16 subsequently elected to do so, leaving 10 states without expansion as of January 2024. As a result of these efforts, roughly 20 million adults gained health insurance coverage.


Medicaid expansion has improved access to primary and preventive care, increased the diagnosis and treatment of cardiometabolic risk factors, and reduced catastrophic health expenditures while also narrowing racial inequities in coverage and access.1 At the same time, states that expanded Medicaid experienced declines in uninsured cardiovascular hospitalizations and increases in access to advanced cardiovascular therapies. Perhaps most importantly, Medicaid expansion has likely improved health—one study estimated the first 4 years of expansion saved nearly 20 000 lives, driven by reductions in cardiovascular deaths.2


Another key step forward under the ACA was the requirement that private plans provide certain preventive services with zero out-of-pocket costs. This policy change had important effects on the use of preventive services for cardiometabolic conditions. The ACA also prohibited health plans from denying coverage to patients with preexisting conditions, increasing

同样,保险业的合并也使保险公司得以将高昂的医疗价格转嫁给消费者,而消费者在保险方面的选择却很少。虽然联邦政府加大了对医疗系统并购的监督力度,并在必要时提出异议,但跨市场的整合在很大程度上被忽视了。这导致美国的大部分医疗服务都由大型医疗系统提供。与此同时,随着私募股权公司的涌入,医疗行业正日益金融化,这些公司专注于通过收购不同的医疗实体来实现短期利润的最大化,12 以及最近管理医疗保险福利的私人医疗保险优势计划的激增,目前已覆盖了美国一半的人口。由于利益相关者数量庞大且不断增加,美国的医疗环境变得异常复杂,导致行政负担和浪费成倍增加。由于这些浪费的成本也以每月高额保费的形式由患者承担,因此几乎没有减少浪费的压力。迄今为止,政策对利用率的过度关注掩盖了医疗支出的这些关键驱动因素,未来的政策举措必须以有意义的方式针对定价失误和行政复杂性。最后,鉴于美国的医疗结果比许多其他国家都要糟糕,许多政策制定者都将精力集中在提高质量的政策解决方案上。然而,越来越多的证据表明,与其他国家相比,美国的医疗系统在很大程度上为心肌梗死等急性病患者提供了类似甚至更好的医疗服务。13 相反,政策制定者却未能正视更有可能导致美国健康结果不佳的因素--在获得初级和预防性医疗服务方面普遍存在的差异,收入、财富和教育方面日益扩大的不平等,以及机会地域的不平等,14 这些因素共同导致了美国各县之间 20 年的预期寿命差异。CMS 已开始鼓励医疗系统识别与健康相关的社会需求,但还需要采取更广泛的跨部门州和联邦政策行动,以解决导致健康状况不佳的潜在社会因素(如贫困),这些因素对美国少数民族人口的影响尤为严重。自 1965 年建立医疗保险和医疗补助计划以来,联邦和州的医疗政策一直是美国医疗成果和支出的主要驱动力。虽然最近保险和覆盖面的扩大与健康状况的改善有关,但在未来的一个世纪中,改善可负担性、将我们的系统重点放在获取和预防上、解决目前医疗保健支出高的驱动因素(单位价格/行政成本、合并和医疗保健金融化)以及解决医疗结果中不可接受的不平等问题等政策努力都是需要关注的重要领域。无。披露 Wadhera 博士接受了美国国家心肺血液研究所的研究资助,并担任雅培、CVS Health 和 Chamber Cardio 的顾问。Joynt Maddox博士报告说,他接受了美国国家心肺血液研究所、美国国家护理研究所和美国国家老龄化研究所的研究资助,并从Humana和Centene公司领取个人酬金,但不包括提交的工作。这篇文章是整个美国心脏协会期刊系列的一部分,由国际思想领袖撰写,内容涉及心脑血管研究和护理的过去、现在和未来。要浏览全部百年纪念文集,请访问 https://www.ahajournals.org/centennial.The 本文所表达的观点不代表编辑或美国心脏协会的观点。有关资金来源和披露,请参阅第 307 页和第 308 页。
{"title":"Policy Strategies to Advance Cardiovascular Health in the United States—Building on a Century of Progress","authors":"Rishi K. Wadhera, Karen E. Joynt Maddox","doi":"10.1161/circoutcomes.123.010149","DOIUrl":"https://doi.org/10.1161/circoutcomes.123.010149","url":null,"abstract":"<p>The US health care system has undergone remarkable transformation over the past century. Policy proposals to create a national health insurance system date back decades and have faced multiple political headwinds but focused on similar and consistent themes: achieving universal health care coverage, containing high and rising health care costs, and increasing competition among private plans.</p><br/><p>When President Obama came to office in 2008, his administration faced compounding health system challenges. Nearly 45 million Americans lacked health insurance coverage. Concerns that private plans were overtly prioritizing profits rather than patients had intensified. National health care costs had risen to 17% of the gross domestic product. At the same time, health outcomes in the United States were worse than comparable countries. In 2010, President Obama signed the Affordable Care Act (ACA) into law, which had 3 areas of focus: expanding coverage through public and private payers, reforming health insurance markets to be more patient-friendly, and improving quality of care and reducing spending through value-based payment programs.</p><br/><p>The ACA addressed high noninsurance rates in the United States with an individual mandate, which required most people to obtain health insurance, and by creating government-run public marketplaces (exchanges) where individuals could obtain insurance plans, often subsidized for lower income buyers. At the same time, the ACA also expanded Medicaid coverage to all adults with incomes up to 138% of the federal poverty level. Though this was intended to be a national expansion, a later Supreme Court challenge established it as optional; consequently, 25 states (including DC) expanded Medicaid in 2014, and an additional 16 subsequently elected to do so, leaving 10 states without expansion as of January 2024. As a result of these efforts, roughly 20 million adults gained health insurance coverage.</p><br/><p>Medicaid expansion has improved access to primary and preventive care, increased the diagnosis and treatment of cardiometabolic risk factors, and reduced catastrophic health expenditures while also narrowing racial inequities in coverage and access.<sup>1</sup> At the same time, states that expanded Medicaid experienced declines in uninsured cardiovascular hospitalizations and increases in access to advanced cardiovascular therapies. Perhaps most importantly, Medicaid expansion has likely improved health—one study estimated the first 4 years of expansion saved nearly 20 000 lives, driven by reductions in cardiovascular deaths.<sup>2</sup></p><br/><p>Another key step forward under the ACA was the requirement that private plans provide certain preventive services with zero out-of-pocket costs. This policy change had important effects on the use of preventive services for cardiometabolic conditions. The ACA also prohibited health plans from denying coverage to patients with preexisting conditions, increasing ","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140608566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sustainable Approach to Justice, Equity, Diversity, and Inclusion Through Better Quality Measurement 通过更好的质量衡量实现公正、公平、多样性和包容性的可持续方法
Pub Date : 2024-04-15 DOI: 10.1161/circoutcomes.123.010791
Nkem Okeke, Kerrilynn C. Hennessey, Amy M. Sitapati, Dana Weisshaar, Nishant P. Shah, Rebecca Alicki, Howard Haft
The US health care industry has broadly adopted performance and quality measures that are extracted from electronic health records and connected to payment incentives that hope to improve declining life expectancy and health status and reduce costs. While the development of a quality measurement infrastructure based on electronic health record data was an important first step in addressing US health outcomes, these metrics, reflecting the average performance across diverse populations, do not adequately adjust for population demographic differences, social determinants of health, or ecosystem vulnerability. Like society as a whole, health care must confront the powerful impact that social determinants of health, race, ethnicity, and other demographic variations have on key health care performance indicators and quality metrics. Tools that are currently available to capture and report the health status of Americans lack the granularity, complexity, and standardization needed to improve health and address disparities at the local level. In this article, we discuss the current and future state of electronic clinical quality measures through a lens of equity.
美国医疗保健行业已广泛采用从电子健康记录中提取的绩效和质量衡量标准,并将其与支付激励措施挂钩,希望以此改善不断下降的预期寿命和健康状况,并降低成本。虽然基于电子健康记录数据的质量衡量基础设施的开发是解决美国健康结果问题的重要的第一步,但这些反映不同人群平均表现的衡量标准并不能充分调整人群的人口差异、健康的社会决定因素或生态系统的脆弱性。与整个社会一样,医疗保健必须正视健康的社会决定因素、种族、民族和其他人口统计差异对关键医疗保健绩效指标和质量指标的强大影响。目前可用于捕捉和报告美国人健康状况的工具缺乏改善健康状况和解决地方差距所需的粒度、复杂性和标准化。在本文中,我们将从公平的角度探讨电子临床质量测量的现状和未来。
{"title":"Sustainable Approach to Justice, Equity, Diversity, and Inclusion Through Better Quality Measurement","authors":"Nkem Okeke, Kerrilynn C. Hennessey, Amy M. Sitapati, Dana Weisshaar, Nishant P. Shah, Rebecca Alicki, Howard Haft","doi":"10.1161/circoutcomes.123.010791","DOIUrl":"https://doi.org/10.1161/circoutcomes.123.010791","url":null,"abstract":"The US health care industry has broadly adopted performance and quality measures that are extracted from electronic health records and connected to payment incentives that hope to improve declining life expectancy and health status and reduce costs. While the development of a quality measurement infrastructure based on electronic health record data was an important first step in addressing US health outcomes, these metrics, reflecting the average performance across diverse populations, do not adequately adjust for population demographic differences, social determinants of health, or ecosystem vulnerability. Like society as a whole, health care must confront the powerful impact that social determinants of health, race, ethnicity, and other demographic variations have on key health care performance indicators and quality metrics. Tools that are currently available to capture and report the health status of Americans lack the granularity, complexity, and standardization needed to improve health and address disparities at the local level. In this article, we discuss the current and future state of electronic clinical quality measures through a lens of equity.","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140608588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Institutes of Health Stroke Scale Reporting in Medicare Claims Data: Reporting in the First 3 Years 美国国立卫生研究院医疗保险报销数据中的卒中量表报告:头三年的报告
Pub Date : 2024-04-10 DOI: 10.1161/circoutcomes.123.010388
Laura K. Stein, Edwin Ortiz, Jaan Nandwani, Mandip S. Dhamoon
BACKGROUND:Since 2016, hospitals have been able to document International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes for the National Institutes of Health Stroke Scale (NIHSS). As of 2023, the Centers for Medicare & Medicaid Services uses NIHSS as a risk adjustment variable. We assessed associations between patient- and hospital-level variables and contemporary NIHSS reporting.METHODS:We performed a retrospective cross-sectional analysis of 2019 acute ischemic stroke admissions using deidentified, national 100% inpatient Medicare Fee-For-Service data sets. We identified index acute ischemic stroke admissions using the ICD-10-CM code I63.x and abstracted demographic information, medical comorbidities, hospital characteristics, and NIHSS. We linked Medicare and Mount Sinai Health System (New York, NY) registry data from 2016 to 2019. We calculated NIHSS documentation at the patient and hospital levels, predictors of documentation, change over time, and concordance with local data.RESULTS:There were 231 383 index acute ischemic stroke admissions in 2019. NIHSS was documented in 44.4% of admissions and by 66.5% of hospitals. Hospitals that documented ≥1 NIHSS were more commonly teaching hospitals (39.0% versus 5.5%; standardized mean difference score, 0.88), stroke certified (37.2% versus 8.0%; standardized mean difference score, 0.75), higher volume (mean, 80.8 [SD, 92.6] versus 6.33 [SD, 14.1]; standardized mean difference score, 1.12), and had intensive care unit availability (84.9% versus 23.2%; standardized mean difference score, 1.57). Adjusted odds of documentation were lower for patients with inpatient mortality (odds ratio, 0.64 [95% CI, 0.61–0.68]; P<0.0001), in nonmetropolitan areas (odds ratio, 0.49 [95% CI, 0.40–0.61]; P<0.0001), and male sex (odds ratio, 0.95 [95% CI, 0.93–0.97]; P<0.0001). NIHSS was documented for 52.9% of Medicare cases versus 93.1% of registry cases, and 74.7% of Medicare NIHSS scores equaled registry admission NIHSS.CONCLUSIONS:Missing ICD-10-CM NIHSS data remain widespread 3 years after the introduction of the ICD-10-CM NIHSS code, and there are systematic differences in reporting at the patient and hospital levels. These findings support continued assessment of NIHSS reporting and caution in its application to risk adjustment models.
背景:自 2016 年起,医院可以记录美国国立卫生研究院卒中量表(NIHSS)的国际疾病分类第十版临床修订版(ICD-10-CM)代码。自 2023 年起,美国医疗保险和医疗补助服务中心(Centers for Medicare & Medicaid Services)将 NIHSS 作为风险调整变量。我们评估了患者和医院层面的变量与当代 NIHSS 报告之间的关联。方法:我们使用去标识化的全国 100% 住院医疗保险收费服务数据集,对 2019 年急性缺血性卒中入院患者进行了回顾性横断面分析。我们使用 ICD-10-CM 代码 I63.x 识别了急性缺血性卒中入院指标,并摘录了人口统计学信息、医疗合并症、医院特征和 NIHSS。我们将 2016 年至 2019 年的医疗保险和西奈山健康系统(纽约州纽约市)登记数据进行了关联。我们计算了患者和医院层面的 NIHSS 记录、记录的预测因素、随时间推移发生的变化以及与当地数据的一致性。44.4% 的入院患者和 66.5% 的医院记录了 NIHSS。记录 NIHSS≥1 次的医院多为教学医院(39.0% 对 5.5%;标准化平均差异分值,0.88)、获得卒中认证的医院(37.2% 对 8.0%;标准化平均差异分值,0.75)、高容量医院(平均值,80.8 [SD, 92.6] 对 6.33 [SD, 14.1];标准化平均差异分值,1.12),以及拥有重症监护室的医院(84.9% 对 23.2%;标准化平均差异分值,1.57)。住院死亡率(几率比,0.64 [95% CI,0.61-0.68];P<0.0001)、非大都市地区(几率比,0.49 [95% CI,0.40-0.61];P<0.0001)和男性性别(几率比,0.95 [95% CI,0.93-0.97];P<0.0001)的患者记录的调整后几率较低。结论:ICD-10-CM NIHSS 编码引入 3 年后,ICD-10-CM NIHSS 数据缺失的现象仍很普遍,患者和医院层面的报告存在系统性差异。这些发现支持继续评估 NIHSS 报告,并在将其应用于风险调整模型时保持谨慎。
{"title":"National Institutes of Health Stroke Scale Reporting in Medicare Claims Data: Reporting in the First 3 Years","authors":"Laura K. Stein, Edwin Ortiz, Jaan Nandwani, Mandip S. Dhamoon","doi":"10.1161/circoutcomes.123.010388","DOIUrl":"https://doi.org/10.1161/circoutcomes.123.010388","url":null,"abstract":"BACKGROUND:Since 2016, hospitals have been able to document <i>International Classification of Diseases, Tenth Revision, Clinical Modification</i> (ICD-10-CM) codes for the National Institutes of Health Stroke Scale (NIHSS). As of 2023, the Centers for Medicare &amp; Medicaid Services uses NIHSS as a risk adjustment variable. We assessed associations between patient- and hospital-level variables and contemporary NIHSS reporting.METHODS:We performed a retrospective cross-sectional analysis of 2019 acute ischemic stroke admissions using deidentified, national 100% inpatient Medicare Fee-For-Service data sets. We identified index acute ischemic stroke admissions using the ICD-10-CM code I63.x and abstracted demographic information, medical comorbidities, hospital characteristics, and NIHSS. We linked Medicare and Mount Sinai Health System (New York, NY) registry data from 2016 to 2019. We calculated NIHSS documentation at the patient and hospital levels, predictors of documentation, change over time, and concordance with local data.RESULTS:There were 231 383 index acute ischemic stroke admissions in 2019. NIHSS was documented in 44.4% of admissions and by 66.5% of hospitals. Hospitals that documented ≥1 NIHSS were more commonly teaching hospitals (39.0% versus 5.5%; standardized mean difference score, 0.88), stroke certified (37.2% versus 8.0%; standardized mean difference score, 0.75), higher volume (mean, 80.8 [SD, 92.6] versus 6.33 [SD, 14.1]; standardized mean difference score, 1.12), and had intensive care unit availability (84.9% versus 23.2%; standardized mean difference score, 1.57). Adjusted odds of documentation were lower for patients with inpatient mortality (odds ratio, 0.64 [95% CI, 0.61–0.68]; <i>P</i>&lt;0.0001), in nonmetropolitan areas (odds ratio, 0.49 [95% CI, 0.40–0.61]; <i>P</i>&lt;0.0001), and male sex (odds ratio, 0.95 [95% CI, 0.93–0.97]; <i>P</i>&lt;0.0001). NIHSS was documented for 52.9% of Medicare cases versus 93.1% of registry cases, and 74.7% of Medicare NIHSS scores equaled registry admission NIHSS.CONCLUSIONS:Missing ICD-10-CM NIHSS data remain widespread 3 years after the introduction of the ICD-10-CM NIHSS code, and there are systematic differences in reporting at the patient and hospital levels. These findings support continued assessment of NIHSS reporting and caution in its application to risk adjustment models.","PeriodicalId":10239,"journal":{"name":"Circulation: Cardiovascular Quality and Outcomes","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140585399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Circulation: Cardiovascular Quality and Outcomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1